Biodefense

Biodefense

H.R.6610 – Director of Pandemic and Biodefense Preparedness and Response Act

Sponsors:  Rep. Rose, Max; Rep. Scanlon, Mary Gay; Rep. Norton, Eleanor Holmes; Rep. Jackson Lee, Sheila; Rep. Foster, Bill.

This bill establishes the position of the Director of Pandemic and Biodefense Preparedness and Response in the executive branch with the following responsibilities:

  • advise the President, relevant councils, and others with respect to pandemics and other health threats
  • oversee the development of a National Pandemic and Biodefense Preparedness and Response Strategy and, in consultation with the Office of Management and Budget, submit biennial reports to Congress on the implementation of the strategy
  • plan for and coordinate specified preparedness and response activities

Current status: Introduced in House (04/23/2020)

More at: https://www.congress.gov/bill/116th-congress/house-bill/6610

H.R.6607 – Strategic National Stockpile Enhancement and Transparency Act

Sponsors:  Rep. Lynch, Stephen F.; Rep. Soto, Darren; Rep. Jackson Lee, Sheila; Rep. San Nicolas, Michael F. Q.; Rep. Hayes, Jahana.

This bill requires the Department of Health and Human Services (HHS) to establish and award grants to states for the implementation of the National Emergency Biodefense Network. The network consists of state entities responsible for tracking and maintaining adequate supplies of drugs, medical devices, and other items necessary for the emergency health security of the United States.

Current status: Introduced in House (04/23/2020)

More at: https://www.congress.gov/bill/116th-congress/house-bill/6607

H.R.6966 – RASPP Act of 2020

Sponsors: Rep. Crow, Jason; Rep. Stefanik, Elise M.; Rep. Jackson Lee, Sheila; Rep. San Nicolas, Michael F. Q.; Rep. Sherrill, Mikie; Rep. Carson, Andre.

The Secretary of Health and Human Services, in cooperation with the Biodefense Steering Committee, shall clarify the national biodefense strategy and associated implementation plan developed under section 1086 of the National Defense Authorization Act for Fiscal Year 2017 (6 U.S.C. 104) to clearly document agreed-upon processes, roles, and responsibilities for making and enforcing enterprise-wide decisions.

Current status: Introduced in House (05/22/2020)

More at: https://www.congress.gov/bill/116th-congress/house-bill/6966

H.R.5730 – National Strategy for Pandemic Influenza Update Act

Sponsors: Rep. Larsen, Rick; Rep. Langevin, James; Rep. Carson, Andre

This bill requires the White House Homeland Security Council (HSC) and the National Security Council (NSC) to update the National Strategy for Pandemic Influenza issued by the HSC in November 2005 within 90 days of this bill’s enactment. The implementation plan associated with the strategy shall be updated not later than 180 days after such an update.

Current status: Introduced in House (01/30/2020)

More at: https://www.congress.gov/bill/116th-congress/house-bill/5730

H.R.1589 – CBRN Intelligence and Information Sharing Act of 2019

Sponsors: Rep. Walker, Mark; Rep. King, Peter T.

This bill expands the functions of the Office of Intelligence and Analysis of the Department of Homeland Security related to homeland-security focused intelligence and information sharing, including: share information and provide tailored analytical support on these threats to state, local, tribal, and territorial authorities and to relevant national biosecurity and biodefense stakeholders and other federal agencies.

Current status: Passed House (04/01/2020)

More at: https://www.congress.gov/bill/116th-congress/house-bill/1589

H.R.6334 – Securing America From Epidemics Act

Sponsors: Rep. Bera, Ami; Rep. Yoho, Ted S.; Rep. Wright, Ron; Rep. Schrier, Kim; Rep. Raskin, Jamie; Rep. Cisneros, Gilbert Ray, Jr.; Rep. Norton, Eleanor Holmes; Rep. Costa, Jim; Rep. Sherman, Brad; Rep. Foster, Bill; Rep. Malinowski, Tom; Rep. Meeks, Gregory W.; Rep. Allred, Colin Z.; Rep. Lieu, Ted; Rep. Smith, Adam; Rep. Gonzalez, Vicente; Rep. Trone, David J.; Rep. Houlahan, Chrissy; Rep. Phillips, Dean; Rep. Blunt Rochester, Lisa; Rep. Spanberger, Abigail Davis.

This bill authorizes the United States to participate in the Coalition for Epidemic Preparedness Innovations (CEPI), an alliance of countries and private partners whose mission is to finance and coordinate the development of vaccines for high-priority, epidemic-potential threats.The President must submit a report outlining (1) planned U.S contributions to, and participation in CEPI, (2) the manner and extent to which the United States shall participate in the governance of CEPI; and (3) how participation in CEPI supports U.S government strategies and programs in health security and biodefense.

Current status: Introduced in House (03/23/2020)

More at: https://www.congress.gov/bill/116th-congress/house-bill/6334

S.2695 – National Bio and Agro-Defense Facility Act of 2019

(Sponsors: Sen. Roberts, Pat; Sen. Stabenow, Debbie; Sen. Grassley, Chuck; Sen. Moran, Jerry; Sen. Smith, Tina; Sen. Blunt, Roy; Sen. Ernst, Joni; Sen. Hyde-Smith, Cindy; Sen. Boozman, John; Sen. Gardner, Cory; Sen. Thune, John; Sen. Shelby, Richard C.; Sen. Fischer, Deb; Sen. Braun, Mike; Sen. McConnell, Mitch; Sen. Hoeven, John; Sen. Leahy, Patrick J.; Sen. Tester, Jon; Sen. Crapo, Mike; Sen. Casey, Robert P., Jr.; Sen. Perdue, David; Sen. Rounds, Mike; Sen. Durbin, Richard J.; Sen. Johnson, Ron; Sen. Peters, Gary C.; Sen. Loeffler, Kelly)

This bill provides statutory authority for the Department of Agriculture (USDA) to act through the National Bio and Agro-Defense Facility to provide integrated research and development to defend US agriculture and food against bio and agro-terrorism threats. Specifically, the bill requires USDA to use the facility to implement research and development objectives to (1) develop veterinary countermeasures for emerging foreign animal diseases and animal transboundary diseases; and (2) provide advanced test, diagnostic, and evaluation capability for threat detection, vulnerability assessment, and veterinary countermeasure assessment for animal and zoonotic diseases.

Current status: Introduced in Senate 10/24/2019

More at: https://www.congress.gov/bill/116th-congress/senate-bill/2695

S.3302 – Global Health Security Act of 2020

Sponsors: Sen. King, Angus S., Jr.; Sen. Van Hollen, Chris

This bill establishes a permanent presidentially appointed position to manage outbreak response efforts. Specifically, the bill establishes the role of Special Advisor for Global Health Security who shall (1) serve as the President’s principal advisor on global health security and global health emergencies (2) coordinate U.S efforts to carry out global health security activities, and (3) convene the Global Health Security Interagency Review Council.

The bill establishes such a council to provide policy guidance to participating agencies on global health security matters and to facilitate the implementation of the existing Global Health Security Agenda. The Special Advisor must also develop a strategy to advance global health security and other specified policy objectives and coordinate a whole-of-government approach to the implementation of such a strategy. In addition, the Department of State must coordinate and facilitate interagency, multi-sectoral activities outside of the United States in response to a declared global health emergency.

Current status: Introduced in Senate (02/13/2020)

More at: https://www.congress.gov/bill/116th-congress/senate-bill/3302

S.3656 – Global Health Security Act of 2020

Sponsors: Sen. Murphy, Christopher; Sen. Romney, Mitt.

This bill is intended to authorize a comprehensive, strategic approach for United States foreign assistance to developing countries to strengthen global health security, and for other purposes.

Current status: Introduced in Senate (05/07/2020)

More at: https://www.congress.gov/bill/116th-congress/senate-bill/3656